Trasylol Quick Reference Guide
Generic name
• Aprotinin
Date approved
• August 1998
Manufacturer
• Bayer
Status
• On the market
Approved use
• Blood loss prevention
Serious side effects
• Kidney failure
• Stroke
• Heart attack
• Heart failure
If you or a loved one have suffered from taking Trasylol, please call 1-888-341-1405 or contact us today to speak to an attorney.
What is Trasylol?
Trasylol (aprotinin), is a coagulant marketed by Bayer Corp.
Who takes it, and for what condition?
It is used post surgery to assist in coagulation. Most commonly it is used in heart bypass and valve replacement or repair surgeries.
How does Trasylol work?
Trasylol slows or prevents bleeding and helps reduce blood loss.
Studies have shown Trasylol may increase the risk of death, serious kidney failure, congestive heart failure, and strokes.
Other drugs, Amocar (aminocaproic acid) and Cyklokapron (tranexamic acid), are used for the same purposes, and have been deemed safe and effective, at a fraction of the cost of Trasylol.
What can you do?
The use of the medication is often not disclosed to the patient. Investigation will require a review of the surgical record to ascertain the use of Trasylol in the particular case. However, if you had heart surgery and suffered kidney failure, congestive heart failure or a stroke, please contact attorney Marilyn T. McGoldrick for more details.
Trust our Massachusetts products liability attorneys to help
Contact the Boston law firm of Thornton Law Firm LLP online or at 1-888-341-1405 or a free consultation with a recognized leader in Massachusetts defective drug litigation. You have nothing to risk. We offer a fair and accurate assessment of your case.
